e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cytokines in pulmonary arterial hypertension: consider sensitivity when using multiplex technology
Monneret Denis
Source:
Eur Respir J 2014; 44: 547-549
Journal Issue:
August
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Monneret Denis. Cytokines in pulmonary arterial hypertension: consider sensitivity when using multiplex technology. Eur Respir J 2014; 44: 547-549
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with
BMPR2
mutation
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
A new molecular genetic diagnostic approach for pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Multi-omic profiling in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Year: 2020
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
Source: Eur Respir Rev, 29 (156) 200009; 10.1183/16000617.0009-2020
Year: 2020
Novel biomarkers in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Time for precision medicine in systemic sclerosis-associated pulmonary arterial hypertension
Source: Eur Respir J, 57 (6) 2100205; 10.1183/13993003.00205-2021
Year: 2021
The genetics of pulmonary arterial hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005
The role of the biomarker and the genetic polymorphism of endothelin-1 in pulmonary arterial hypertension among Egyptians
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
A noninvasive algorithm to exclude pre-capillary pulmonary hypertension
Source: Eur Respir J 2011; 37: 1096-1103
Year: 2011
Analysis of pulmonary endothelial microparticles, haemodynamics and functional class in pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Screening pulmonary hypertension by lung doppler signal: A proof-of-concept study
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed
Source: Eur Respir J 2010; 36: 986-990
Year: 2010
Early detection and management of pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21: 306-312
Year: 2012
Novel techniques for advancing our understanding of pulmonary arterial hypertension
Source: Eur Respir J, 53 (5) 1900556; 10.1183/13993003.00556-2019
Year: 2019
Pulmonary arterial hypertension: treatment options
Source: International Congress 2018 – ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED
Year: 2018
Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm
Source: Eur Respir J 2015; 46: 299-302
Year: 2015
Single arterial occlusion to locate resistance in patients with pulmonary hypertension
Source: Eur Respir J 2003; 21: 31-36
Year: 2003
IL-6 in pulmonary hypertension: why novel is not always best
Source: Eur Respir J, 55 (4) 2000314; 10.1183/13993003.00314-2020
Year: 2020
Challenges in the diagnosis and treatment of pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21: 313-320
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept